We hypothesize that tumor cells may adapt by upregulating alternative pathways, such as D-dopachrome tautomerase (DDT, a.k.a. MIF-2), with host MIF influencing initial tumor establishment and tumor-secreted MIF being sufficient to support subsequent growth and progression. Here, MIF is linked to neoplasm.